Fabryconnect.com is intended for United States residents only.


Dear Fabry Community,
During this challenging time with the global COVID-19 outbreak, it is all the more important we look out for and support one another. Your safety and welfare and that of your families always has been and continues to be Amicus' number one priority. Our commitment to the rare disease community will continue and we are only a phone call or email away. For questions or support, we can be reached at patientadvocacy@amicusrx.com or toll-free in the US at 1(866) 9-AMICUS (926-4287). NP-NN-ALL-00030520


About FabryConnect.com

Sponsored by Amicus Therapeutics

At Amicus Therapeutics, Inc we try to make all our decisions as if we were living with a rare disease or were caring for someone who is. We ask ourselves "what would be important to me" if I was a person living with Fabry disease? What would be a meaningful advancement or a risk I would take?

To that end, we:

  • Listen and learn from individuals and their families affected by these diseases;
  • Search for new and better therapies;
  • Incorporate patient input into the design of clinical trials for those therapies as our research advances through the drug development process; and
  • Provide useful information and resources to help manage the daily challenges of living with a rare, genetic disease.

Amicus Therapeutics is a global biotechnology company at the forefront of advanced therapies to treat a range of serious rare diseases.